| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.06 | 0.3 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.06 | 0.3 |